Skip to main content

COVID-19 Phase 3 Assess Efficacy of Ruxolitinib

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Incyte Corporation

Start Date

May 1, 2020

End Date

December 28, 2021
 

Administered By

Duke Cancer Institute

Awarded By

Incyte Corporation

Start Date

May 1, 2020

End Date

December 28, 2021